← SynDRA
Tocris-1207
SynDRA canonical compound SYN0704811 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | HTR1D |
|---|
| Mechanism of action | Serotonin receptor antagonist |
|---|
All known targets
- HTR1D
- HTR1A
- HTR1B
- HTR1E
- HTR1F
- HTR2A
- HTR2B
- HTR2C
- HTR6
Mechanisms of action (all sources)
- Serotonin receptor antagonist
- HTR1A PARTIAL AGONIST
- HTR1B PARTIAL AGONIST
- HTR1D PARTIAL AGONIST
- HTR1E PARTIAL AGONIST
- HTR1F PARTIAL AGONIST
- HTR2A FULL AGONIST
- HTR2B PARTIAL AGONIST
- HTR2C PARTIAL AGONIST
- HTR6 PARTIAL AGONIST
- 5-ht1d receptor antagonist
- HTR1F AGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- Lopac-B-9929
- NCGC00015173-01
- NCGC00025039-01
- 3-(4-(3-Chlorophenyl)piperazin-1-yl)-1,1-diphenyl-2-propanol
- CCG-204280
- BRL-15572dihydrochloride
- HY-13200
- BPBio1_000265
- 3-[4-(3-chlorophenyl)piperazin-1-yl]-1,1-diphenylpropan-2-ol
- H37475
- BRL-15,572
- BRD-A51829654-003-02-8
- SB19509
- HY-13200B
- 3-(4-(3-Chlorophenyl)-1-piperazinyl)-1,1-diphenyl-2-propanol
- T62596
- EU-0100185
- 4-(3-Chlorophenyl)-alpha-(diphenylmethyl)-1-piperazineethanol dihydrochloride
- RefChem:1056572
- B 9929
- UNII-LY8CZE6XUD
- CHEBI:64057
- 3-(4-(3-Chlorophenyl)piperazin-1-yl)-1,1-diphenylpropan-2-ol
- NCGC00093663-01
- J878.866I
- BRL-15572 dihydrochloride
- BRL 15572 hydrochloride
- A12209
- s2677
- BRL-15572 (dihydrochloride)
- Biomol-NT_000118
- JEB51740
- DA-71739
- AKOS037649318
- SR-01000075549-1
- BRL-15572 2HCl
- E74570
- CS-0024603
- LP00185
Look up Tocris-1207 in the interactive SynDRA portal →